| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6119473 | Journal of Clinical Virology | 2016 | 9 Pages |
Abstract
This preliminary report suggests that CD28-positive CMV-specific CTL could be put at the first line, as possible novel marker associated with CMV viremia development.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Maciej Msc, Agnieszka MD, Ph.D, Hanna Msc, Ph.D, Magdalena MD, Ph.D, Grażyna Msc, Ph.D, Alicja (Prof.), BolesÅaw (Prof.), Piotr (Prof.),